Technology
Health
Biotechnology

Phio Pharmaceutical

$0.452
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.004 (-0.88%) Today
$0.00 (0.00%) After Hours

Why Robinhood?

You can buy or sell PHIO and other stocks, options, ETFs, and crypto commission-free!

About

Phio Pharmaceuticals Corp. Common Stock, also called Phio Pharmaceutical, is a biotechnology company, which engages in the development of immuno-oncology therapeutics that address unmet medical needs. Read More Its clinical product candidate includes RXI-109, a RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.

Employees
9
Headquarters
Marlborough, Massachusetts
Founded
2011
Market Cap
8.59M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
677.70K
High Today
$0.475
Low Today
$0.452
Open Price
$0.456
Volume
63.99K
52 Week High
$2.58
52 Week Low
$0.27

Collections

Technology
Health
Biotechnology
Medical
Therapy
US
North America

Earnings

-$0.90
-$0.60
-$0.30
-$0.00
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Estimated
-$0.08 per share
Actual
-$0.10 per share

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.